Has Nabil Baradhi received payments from drug or device companies?

Yes. Drug and device makers reported $2,917 in general payments to Nabil Baradhi across 140 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nabil Baradhi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nabil Baradhi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nabil Baradhi

Cardiovascular Disease · Lake Jackson, TXNPI 1699774117

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $994 and has fallen 93.4% since, to $66 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in TX, where the typical reported total is $3,258.

$2,917in general payments, 2019–2025

Across 140 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$699
Abbott$590
Amgen$318
Boston Scientific$250
Shockwave Medical, Inc$190
Merck$157
plus $713 from 12 others

What the payments were for

Food & beverage$2,917100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	53	$699
Abbott	11	$590
Amgen	17	$318
Boston Scientific	6	$250
Shockwave Medical, Inc	1	$190
Merck	6	$157
Kowa Pharmaceuticals America, Inc.	14	$145
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	9	$113
E.r. Squibb & Sons, L.L.C.	5	$90
Novartis	4	$76
Sanofi-aventis U.S. LLC	3	$73
AstraZeneca	2	$48
Regeneron Healthcare Solutions, Inc.	2	$33
Bayer	2	$32
Pfizer	2	$28
Heartflow, Inc.	1	$28
Osprey Medical Inc	1	$25
Medtronic	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,917 in reported general payments places this provider in the 45th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Other cardiovascular disease in Lake Jackson

Ramin Farzaneh-FarDallas$17.1M
John OsborneGrapevine$1.3M
Darren McGuireDallas$1.2M
Peter McCulloughDallas$664K
Ann NavarDallas$616K
Biykem BozkurtHouston$606K
Milton PackerDallas$530K
Amarinder BindraDallas$512K
Robert SalazarKingwood$478K
Reynolds DelgadoHouston$471K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →